Inspection Record

Avella of Deer Valley dba Avella Specialty Pharmacy — FDA 483 Findings

US FDAInspected 2018-04-25Published 2026-03-23 3 findingsAseptic processing and sterility assuranceQuality unit oversightLabeling and packaging

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the equipment to produce aseptic conditions.

2Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not fully followed.

3Labeling and packaging

The container labels of yom outsourcing facility's drug products are deficient.

About this record

Extracted automatically from the document US FDA published on 2026-03-23. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2018-04-19 · US FDA · 3 findings
Avella of Deer Valley dba Avella Specialty Pharmacy company profile — full history US FDA documents, 2026 Go to Findings search